Ep 113 Pulmonary Embolism Challenges in Diagnosis Part 1

This is EM Cases Episode 113 Pulmonary Embolism Challenges in Diagnosis Part 1.

If we were to design a perfect emergency medicine brain buster, it would have all the qualities of pulmonary embolism. It would affect the young and the old. It would be precipitated by seemingly anything: medications, smoking, and even video gaming. It would be dynamic, anything from asymptomatic to killing in minutes. It would have a huge variability in presenting signs and symptoms depending on a whole host of patient factors. It would have multiple decision rules, imaging modalities, and treatment options. It’s as if pulmonary embolism was invented just to challenge the minds of ED docs! In this two part podcast, with the help of thrombosis experts Dr. Kerstin DeWit and Dr. Eddy Lang, we ask the questions that plague us on almost every shift: Which patients require any work-up at all for pulmonary embolism? What’s the utility of PERC and Wells scores? Should the newer YEARS decision tool supplant Wells? When should we order a D-dimer? What is the diagnostic role of CXR, ECG, POCUS, CTA and VQ? How should we work up pregnant patients for pulmonary embolism? How can we use shared decision making strategies for pulmonary embolism to help us do what’s best for our patients, and many more…

Podcast production & sound design by Anton Helman, editing by Sucheta Sinha & Anton Helman

Written Summary and blog post by Shaun Mehta & Alexander Hart, edited by Anton Helman, August 2018

The diagnosis of PE is a tricky one. It is hardly gratifying when we find an incidental subsegmental filling defect in a 90-year-old patient with multiple comorbidities but missing a larger clot in an otherwise young and healthy patient can be devastating. The problem is, with such a wide variability in presentation and without clear diagnostic directives from the literature, it can be hard to tease apart those who are sick from those who don’t have the disease at all.

What we really want are decision aids that maximize diagnostic accuracy while minimizing over-testing and patient harm resulting from over-testing, over-diagnosis and anticoagulant complications.

 

Pulmonary embolism challenges in diagnosis: What’s all the fuss really about anyways?

PEs kill. But not as much as we might think.

In the 1990’s The Prospective Investigation of Pulmonary Embolism Diagnosis study found a case fatality rate of 15% at 3 months [1], but only 10% of these deaths were directly attributable to PE [2]. Newer data from the EMPEROR Registry in 2011 found that the mortality rate directly attributed to PE was 1%, while the all-cause 30-day mortality rate was 5.4%, and mortality from hemorrhage was 0.2% [3]. Interestingly, most patients who died (85%) succumbed untreated while waiting for diagnostic confirmation. It appears from this data that most patients with PE die of comorbidities which might have placed the patient at risk for PE, such as malignancy or die while waiting for diagnostic confirmation. Much of this decreased mortality may be related to the increase in diagnosis of subsegmental PEs in the past two decades. Comparison of pooled data from uncontrolled outcome studies shows no increase in PE recurrence or death rates for patients diagnosed with isolated subsegmental PEs who were not anticoagulated compared to those who were anticoagulated [4].

 

What about the bleeding risk in treated pulmonary embolism? 

The typical patient being worked up for PE is low risk for the diagnosis and at low risk for bleeding complications. In the same 2018 metaanalysis looking at outcomes of subsegmental PEs, 8% of those anticoagulated had a significant bleeding complication [4]. The risk for a major bleed for all comers diagnosed with PE is around 3-5% in the first 3 months of treatment. Most of these will occur in the first week. It is important to weigh the likelihood of PE against the risk of bleeding prior to starting anticoagulation on speculation in the ED. The HAS-BLED score can help here. On the other hand, one or two doses of anticoagulant medication portends a negligible risk for major bleeding complications; ED patients with a high pretest probability for PE who have no absolute contraindications to anticoagulation, should be anticoagulated prior to diagnostic confirmation, as 85% of PE mortality in ED patients occured in untreated patients waiting for diagnostic confirmation in the EMPEROR Registry.

 

Pitfalls in the diagnosis of pulmonary embolism

Failure to consider the diagnosis in patients with comorbidities. A missed PE is rarely a failure of diagnostic strategy; it’s more often a failure to consider the diagnosis to begin with. A PE is easy to miss in those with co-morbidities (e.g. CHF, pneumonia) – premature closure in patients with a clear reason for their shortness of breath or who are going to be admitted for other reasons is one source of missed diagnosis.

Overestimating the risk of PE. While we might think we see a lot of patients that are high risk for PE, the vast majority of patients who we are considering for PE diagnosis are in fact, low risk according to Well’s Criteria. We order many needless CTPAs, with their inherent problems of overdiagnosis and radiation risk, for fear of a PE in low risk and negligible risk patients. Remember that placing PE in the top three considerations in your differential diagnosis of a patient who presents with chest pain or shortness of breath does not necessarily mean they are at high risk for PE. Even experienced clinicians have been shown to overestimate the risk of PE in low risk patients.

Misinterpretation of vital signs. One source of over-testing is misinterpreting the contribution of heart rate to the pretest probability. While tachycardia is one of the points in the Well’s score, tachycardia in the absence of any other features of pulmonary embolism should not trigger the work-up. Conversely, a normal heart rate does not rule out PE. An important nuance is that a triage tachycardia that normalizes by the time the patient is assessed by the ED physician, according to a recent study, should be considered tachycardia when using the Wells score. In this study, in patients with an abnormal pulse rate, respiratory rate, shock index, or pulse oximetry at triage that subsequently normalized, the prevalence of PE was 18, 14, 19, and 33%, respectively [5].

Assuming low risk for PE in patients with no apparent risk factors. While risk factor assessment is important in assessing pretest probability, up to 50% of PEs are diagnosed in patients with no apparent risk factors [6].

 

Pearls in decision making on whether or not to work up a patient for pulmonary embolism

Take your time taking a history

Few will miss the woman on OCP who traveled in a trans-Atlantic plane a week ago who comes in dyspneic, coughing up blood with a swollen leg and a history of cancer. For the less clear cut patients there are some pearls to consider when taking a history. 

Is it true exertional dyspnea? Where we need to drill down when it comes to assessing symptoms is whether the patient is experiencing true exertional dyspnea or not. Many patients will admit to feeling short of breath if you ask them “have you felt short of breath at all?”, but this will inevitably label patients with dyspnea who do not in fact have dyspnea. You are more likely to identify true dyspnea if you ask the patient “how is your breathing” and “give me an example of when you feel breathless”. If the patient says that when they walk their dog they emergency management of pediatric seizuresneed to stop every few steps to catch their breath, this is more likely to be true exertional dyspnea than the patient tells you that they sometimes feel the need to take one or two deeper breaths while watching television.

Fatigue is an overlooked symptom of pulmonary embolism. A common symptom in PE is fatigue, which while non-specific, should raise an eyebrow in the dyspneic patient who tells you that they developed unusual fatigue that coincides with their dyspnea.

 

How should risk factors contribute to the pretest probability of pulmonary embolism?

While there is an ever-growing long list of risk factors for PE the important risk factors to consider in assessing pretest probability include personal and family history of venous thromboembolism, recent immobilization, active cancer and exogenous estrogen use. These are the risk factors that should be considered in your assessment of  pretest probability for PE.

Nonetheless, it is important to realize that up to 50% of PEs are diagnosed in patients with no apparent risk factors [6].

 

Up to 50% of pulmonary embolisms are diagnosed in patients with no apparent risk factors.

 

Which patients who present to the ED with syncope or COPD exacerbation require a CTPA to rule out pulmonary embolism?

The PESIT trial [7]

Although this study showed a startling 17% PE prevalence in patients admitted to hospital with syncope, there are some important points to consider:

  • This trial was conducted on those already admitted to hospital. The results are not generalizable to the ED population.
  • subsequent international study showed a <1% prevalence of PE in those who presented to EDs with syncope [8].
  • A Canadian study showed a 1.4% prevalence of PE in those admitted with syncope [9].

A reasonable approach therefore would be to assess your syncope patients for PE the way you would any other patient in the ED.

  

Is COPD the only thing making my patient short of breath?

While one of the sources of missed PE is not considering the diagnosis in patients with respiratory comorbidities, and PE should be considered in patients presenting with unexplained COPD exacerbations, not every COPD patient requires a CTPA in the ED. A 2017 systematic review and meta-analysis showed a PE prevalence of 16% in patients with unexplained acute COPD exacerbations [10]. However, they only included a single ED study which had a PE prevalence of only 3%, and the clinical significance of these PEs were unclear – one third of the PEs were subsegmental. This a tricky patient population. On the one hand they have poor respiratory reserve at baseline. A second hit from a PE will not be well tolerated. On the other hand, they are at higher risk of catastrophic bleeding given their comorbidities and frailty. So where does this leave us with regards to ordering CTPAs on patients with COPD exacerbations in the ED? Make sure the story fits. If the typical clinical features of COPD exacerbation are missing, or the patient has some features of PE, a workup for PE should be considered. Patients with typical COPD exacerbations with wheeze who have an identifiable infectious source on chest x-ray are unlikely to require a CTPA to rule out PE. 

 

Suggested diagnostic decision tool algorithm for pulmonary embolism. 

There are a number of decision rules that are used as objective aids in the work up of PE. Wells and PERC (Pulmonary Embolism Rule out Criteria) are the two most commonly utilized tools in North American EDs. It is important to understand how the prevalence of PE in your population impacts decision making. Simply put, the prevalence of a disease can be considered the pre-test probability of the patient ruling in for that disease. The maximum suggested prevalence for PE in order to use the PERC rule is 7%. In other words, if there is a high prevalence of PE in your population, PERC may not be applicable.

The PROPER trial out of France, where the prevalence of PE is low, showed that gestalt performed similarly to PERC in terms of 3-month PE rate, but PERC resulted in an 8% decrease in unnecessary CT scanning, and a 40-minute decrease in ED stay [11]. While studies have suggested that physician gestalt may be as accurate as these decision tools [11,12], there is an argument to be made that even seasoned docs should take the time to calculate these scores because even they can have a tendency to overestimate pretest probability at times.

 

An Algorithmic Approach

Once you have decided to test for PE, our experts suggest starting with Wells to get an idea of the pre-test probability.

1.     If <2, use PERC

2.     If 2-4, send D-dimer

3.     If >4, consider a CTPA

 

Should The YEARS Algorithm supplant Wells?

The YEARS score is essentially a simplified Wells, and uses two different D-dimer thresholds to direct the work up of PE. Limitations of the YEARS study [13,14] include the physicians not being blinded to the initial D-dimer, and higher PE rates compared to other studies. Our experts believe that while promising, the YEARS algorithm requires further study.

pulmonary embolism challenges in diagnosis

 

Age-Adjusted D-Dimer

D-dimer threshold = Age (>50) x 10

 

There are conflicting policy statements from different international societies, but the evidence is reasonably convincing for the use of age-adjusted D-dimer [15] and is recommended by our experts. ACEP suggests that using an age-adjusted approach may reduce the need for advanced imaging without significantly increasing missed cases of PE [16]. 

Journal Jam on age-adjusted D-dimer with Jeff Kline

 

Utility of ancillary testing for the diagnosis of pulmonary embolism

CXR. While decades ago we depended more so on CXR and ECG to help in the diagnosis of PE, their utility has recently become less important. Nonetheless, findings on chest X-ray and ECG may aid in your decision making. The main role of a chest X-ray is to rule out alternative diagnoses. Beware of diagnosing pneumonia based on an infiltrate, as a pulmonary infarct from PE can look similar. The chest X-ray is often normal in PE. The classic findings are raised hemidiaphragm, pleural effusion, Westermark’s sign and Hampton’s hump. The latter are usually identified in retrospect after the diagnosis of PE has already been made.

 

ECG. Signs of PE on ECG include sinus tachycardia, RV strain pattern, incomplete RBBB, S1Q3T3, dominant R wave in V1, ST-segment elevation in V1 and aVR and low voltages.

The most specific ECG finding in PE is flipped T waves in anterior AND inferior leads. This finding is almost never found in ischemia-mediated disease. S1Q3T3 has a poor specificity for PE.

 

POCUS. In general, bedside ultrasound will not be your primary modality to diagnose PE. However, it can be helpful in the arrest or peri-arrest patient who are not safe to leave the ED to get a CTPA. Our experts do not recommend using POCUS to aid in disposition decisions. Even if sonographic signs of right heart strain are present, PE can still be managed as an outpatient if criteria for outpatient management are fulfilled.

Rob Simard on POCUS Cases 1: Pulmonary Embolism

 

In part 2 of Pulmonary Embolism Challenges in Diagnosis we discuss nuances of CTPA, workup of PE in pregnant patients, management of subsegmental PEs, implimenting decision support in your ED and much more…

  

Other FOAMed Resources on Pulmonary Embolism Diagnosis

References

  1. Heit JA, Silverstein MD, Mohr DN, Petterson TM, O’Fallon WM, Melton III. Predictors of survival after deep vein thrombosis and pulmonary embolism: a population-based, cohort study.  Arch Intern Med. 1999;159445- 453.
  2. Carson  JL,Kelley  MA,Duff et al.  The clinical course of pulmonary embolism.  N Engl J Med. 1992;3261240- 1245.
  3. Pollack CV, Schreiber D, Goldhaber SZ, et al. Clinical characteristics, management, and outcomes of patients diagnosed with acute pulmonary embolism in the emergency department: initial report of EMPEROR (Multicenter Emergency Medicine Pulmonary Embolism in the Real World Registry). J Am Coll Cardiol. 2011;57(6):700-6.
  4. Bariteau A, Stewart LK, Emmett TW, Kline JA. Systematic Review and Meta-analysis of Outcomes of Patients With Subsegmental Pulmonary Embolism With and Without Anticoagulation Treatment. Acad Emerg Med. March 2, 2018.
  5. Kline JA, Corredor DM, Hogg MM, Hernandez J, Jones AE. Normalization of vital signs does not reduce the probability of acute pulmonary embolism in symptomatic emergency department patients. Acad Emerg Med. 2012;19(1):11-7.
  6. White RH. The epidemiology of venous thromboembolism. Circulation. 2003;107(23 Suppl 1):I4-8.
  7. Costantino G, Ruwald MH, Quinn J, et al. Prevalence of Pulmonary Embolism in Patients With Syncope. JAMA Intern Med. 2018;178(3):356-362.
  8. Prandoni P, et al. Prevalence of Pulmonary Embolism among Patients Hospitalized for Syncope. The New England Journal of Medicine. 2016;375(16):1524-31.
  9. Verma AA, Masoom H, Rawal S, Guo Y, Razak F. Pulmonary Embolism and Deep Venous Thrombosis in Patients Hospitalized With Syncope: A Multicenter Cross-sectional Study in Toronto, Ontario, Canada. JAMA Intern Med. 2017;177(7):1046-1048.
  10. Aleva FE, Voets LWLM, Simons SO, De mast Q, Van der ven AJAM, Heijdra YF. Prevalence and Localization of Pulmonary Embolism in Unexplained Acute Exacerbations of COPD: A Systematic Review and Meta-analysis. Chest. 2017;151(3):544-554.
  11. Freund Y, Cachanado M, Aubry A, et al. Effect of the Pulmonary Embolism Rule-Out Criteria on Subsequent Thromboembolic Events Among Low-Risk Emergency Department Patients: The PROPER Randomized Clinical Trial. JAMA. 2018;319(6):559-566.
  12. Penaloza A, Verschuren F, Meyer G, et al. Comparison of the unstructured clinician gestalt, the wells score, and the revised Geneva score to estimate pretest probability for suspected pulmonary embolism. Ann Emerg Med. 2013;62(2):117-124.e2.
  13. van der Hulle T, Cheung WY, Kooij S, et al. Simplified diagnostic management of suspected pulmonary embolism (the YEARS study): a prospective, multicentre, cohort study. Lancet. 2017;390(10091):289-297.
  14. Kabrhel C, Van hylckama vlieg A, Muzikanski A, et al. Multicenter Evaluation of the YEARS Criteria in Emergency Department Patients Evaluated for Pulmonary Embolism. Acad Emerg Med. 2018.
  15. Righini M, Van es J, Den exter PL, et al. Age-adjusted D-dimer cutoff levels to rule out pulmonary embolism: the ADJUST-PE study. JAMA. 2014;311(11):1117-24.
  16. Wolf SJ, Hahn SA, Nentwich LM, et al. Clinical Policy: Critical Issues in the Evaluation and Management of Adult Patients Presenting to the Emergency Department With Suspected Acute Venous Thromboembolic Disease. Ann Emerg Med. 2018;71(5):e59-e109.

Additional References for the podcast

  1. Kline JA, Neumann D, Haug MA, Kammer DJ, Krabill VA. Decreased facial expression variability in patients with serious cardiopulmonary disease in the emergency care setting. Emerg Med J. 2015;32(1):3-8.
  2. Optimal Strategies for the Diagnosis of Acute Pulmonary Embolism: A Health Technology Assessment. Ottawa: CADTH; 2018 Jan. (CADTH optimal use report; vol.6, no.3b).
  3. Singh B, Parsaik A, Agarwal D, Surana A, Mascarenhas S, Chandra S. Diagnostic accuracy of pulmonary embolism rule-out criteria: a systematic review and meta-analysis. Ann Emerg Med. 2012;59(6):517-20.e1-4. 
  4. Kohn MA1,2, Klok FA3, van Es N4. D-dimer Interval Likelihood Ratios for Pulmonary Embolism. Acad Emerg Med. 2017 Jul;24(7):832-837.
  5. Writing Group for the Christopher Study Investigators*. Effectiveness of Managing Suspected Pulmonary Embolism Using an Algorithm Combining Clinical Probability, D-Dimer Testing, and Computed Tomography. JAMA. 2006;295(2):172-179.
  6. Den exter PL, Van es J, Klok FA, et al. Risk profile and clinical outcome of symptomatic subsegmental acute pulmonary embolism. Blood. 2013;122(7):1144.

 

 

Drs. Helman and Lang have no conflicts of interest to declare. Dr. DeWit receives research funding from Bayer.

Sign up for our Newsletter 

About the Author:

Dr. Anton Helman is an Emergency Physician at North York General in Toronto. He is an Assistant Professor at the University of Toronto, Division of Emergency Medicine and the Education Innovation Lead at the Schwartz-Reisman Emergency Medicine Instititute. He is the founder, editor-in-chief and host of Emergency Medicine Cases.

6 Comments

  1. Bill MacPherson August 14, 2018 at 7:53 pm - Reply

    excellent learning Thank you so much

  2. John Hayes August 20, 2018 at 3:48 pm - Reply

    What’s the consensus on applying PERC in a primary care (GP) setting to low risk patients? I can only find studies validating in an ED rather than General Practice setting. Logically, I can’t see a reason that these two populations should be different for this purpose but can’t currently find anything to back that up.

  3. Emily Conway August 23, 2018 at 12:12 pm - Reply

    Fantastic review!
    If one comes from a perspective of working up a swollen leg with no other symptoms; my understanding is that a negative D-dimer would rule out a DVT. An urgent leg venous doppler would not be necessary and follow up family doctor for other causes of a swollen leg, (edema, baker’s cyst, injury etc) is appropriate. A D-dimer is a cheaper test than a venous doppler for ruling out DVT. I have colleagues that order venous doppler to rule out clot or DVT and not D-dimer. Am I missing something? My thoughts are that a D-dimer is more useful from an EM perspective in the setting of swollen leg. One would treat and order a doppler if positive and if negative then no doppler is necessary and follow-up family doctor.

  4. Dr Ian Light August 30, 2018 at 2:04 am - Reply

    I would trust a venous Doppler better than DDimer which would likely be raised in in many chronic medical illness and gets to the danger fast .
    You can squeeze it in as a test if urgent within 1-3 hours for a family physician with radiology close .
    The PERC rule has a fault as does HAD CLOTS .
    Where is Malignancy ?
    Re COPD : I had a patient not responding to the usual exacerbation of COPD treatment : Bronchodilator nebulisations 4 hrly Oral Cortico Steroids Antibiotics .after 3 days I sent her into emergency .Diagnosis PE .!
    Lack of usual quick response to usual COPD treatment as in 12-24 hours is a warning of serious Comorbidities Heart Failure Pulmonary Embolus .

  5. Emily August 30, 2018 at 12:05 pm - Reply

    I agree about the COPD not getting better. That for me is a major red flag as I,ve picked up several PEs in the those patients but they are usually red flag patients anyway by being bounce backs to the ED. It was an eye opener for me how few PE patients have chest pain.
    Re Leg swelling. D-Dimer would over-call with many false positives and all those patients would all get leg u/s as part of the work-up to find clot. The D-Dimer is a cheaper test than leg u/s so if negative would save the more expensive ultrasound. I’m thinking if one did d-dimer 1st it would save a lot of leg ultrasounds. As for speed of work-up, the d-dimer is faster to get than an u/s. I’m hoping someone will chime in and tell me if this so sound reasoning and if not, why.

  6. Dominic Larose September 3, 2018 at 9:56 pm - Reply

    I would like you to comment about d dimer use depending on duration of symptoms with the sensitivity being too low after 3 or more days.

Leave A Comment